Activin AB is a biotechnology company focused on developing innovative therapies for serious diseases. The company specializes in creating treatments that target specific biological pathways, particularly in the fields of oncology and autoimmune disorders. Founded in Sweden, Activin AB aims to leverage its expertise in protein biology to advance drug discovery and development. The company collaborates with various research institutions and pharmaceutical partners to bring new therapies to market, enhancing patient care and improving health outcomes.